Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist that reduces appetite hormonally, slows gastric emptying, and produces 1520% body weight reduction in clinical trials even without structured dietary intervention
Our formulation is widely used for the reduction of Melanin production and lightens up darker areas such as armpits, dark circles, spots, scars, etc
JH: Formal analysis, Writing review & editing, Data curation, Methodology, Conceptualization, Visualization, Investigation, Software
Consult your veterinarian or animal health consultant for supplementation advice specific to your situation
Boost GLP-1 levels by over 50% to promote satiety and feelings of fullness
Pigmentary changes: Can lead to rapid and noticeable changes in existing moles or nevi, with possible cosmetic or dermatologic implications 2